ERLEADA™ (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics by McKesson
Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, has been selected by the Janssen Pharmaceutical Companies of Johnson & Johnson…